Seroprevalence of HHV-8 antibodies in HIV-positive homosexual men without Kaposi's sarcoma and their clinical follow-up

American Journal of Clinical Pathology

Volumn 109, Issue 6, 1998, Pages 778-783

  Verbeek, Walter ^a,c   Frankel, Matthew ^a   Miles, Steven ^b   Said, Jonathan ^b   Koeffler, H Phillip ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Human herpesvirus 8; Human immunodeficiency virus; Kaposi's sarcoma

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOMOSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROPREVALENCE; VIRUS INFECTION;

EID: 0031806976     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/109.6.778     Document Type: Article

References (24)

1. Beral V, Peterman TA, Berkelman RL, et al. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet. 1990;335:123-128.
2. Wang C-YE, Schroeter A, Su WPD. Acquired immunodeficiency syndrome-related Kaposi's sarcoma. Mayo Clin Proc. 1995;70:869-879.
3. Rutherford GW, Schwarcz SK, Lemp GF. The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco. J Infect Dis. 1989;159:569-572.
4. Serraino D, Franceschi S, Dal Maso L, et al. HIV transmission and Kaposi's sarcoma among European women. AIDS. 1995; 9:971-973.
5. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS associated Kaposi's sarcoma. Science. 1994;265:1865-1869.
6. Cesarman E, Chang Y, Moore PS, et al. Kaposi sarcoma-associated herpesvirus like DNA sequences are present in AIDS-related body cavity based lymphomas. N Engl J Med. 1995;332:1186-1191.
7. Russo JJ, Bohenzky RA, Chien M-C, et al. Nucleotide sequence of the Kaposi sarcoma associated herpesvirus (HHV8). Proc Natl Acad Sci USA. 1996;93:14862-14867.
8. Moore PS, Boshoff C, Weiss RA, et al. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 1996;274:1739-1744.
9. Arvanitakis L, Geras-Raaka E, Varma A, et al. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature. 1997;385:347-349.
10. Li M, Lee H, Yoon D-W, et al. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol. 1997;71:1984-1991.
11. Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol. 1996;70:549-558.
12. Kedes DH, Operskalski E, Busch M, et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med. 1996;2:918-924.
13. Miller G, Rigsby MO, Heston L, et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med. 1996;334:1292-1297.
14. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet. 1996;348:858-861.
15. Andre S, Schatz O, Bogner JR, et al. Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS associated Kaposi's sarcoma. J Mol Med. 1997;75:145-152.
16. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet. 1996;349:1133-1138.
17. Said J, Chien K, Takeuchi S, et al. Kaposi's sarcoma associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood. 1996;87:4937-4943.
18. Humphrey RW, O'Brien TR, Newcomb FM, et al. Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs. Blood. 1996;88:297-301.
19. Gao S-J, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi sarcoma. Nat Med. 1996;2:925-928.
20. Gao SJ, Kingsley L, Hoover D, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med. 1996;335:233-241.
21. Lundgren JD, Melbye M, Pedersen C, et al. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow up. Am J Epidemiol. 1995;141:652-658.
22. Mocroft A, Youle M, Gazzard B, et al. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. AIDS. 1996;10:1101-1105.
23. Morfeldt L, Torssander J. Long term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scand J Infect Dis. 1994;26:749-752.
24. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995;346;799-802.